Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ekaterina Vasil'evna Belotserkovskaya"'
Autor:
D.Yu. Pozdnyakov, Ekaterina Vasil’evna Belotserkovskaya, Kseniya Aleksandrovna Levchuk, Larisa Girshova, A.V. Petukhov, A.Yu. Zaritskey
Publikováno v:
Clinical oncohematology. 14:138-148
NK-cells as innate immunity elements manifest key reactions of antitumor immune response. NKG2D is an activating transmembrane receptor of NK-cells which is responsible for cytotoxicity initiation in response to the binding of specific ligands of gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a98d3f0183c3486730184a5bc992aca8
https://doi.org/10.21320/2500-2139-2021-14-1-138-148
https://doi.org/10.21320/2500-2139-2021-14-1-138-148
Autor:
K.A. Levchuk, Ekaterina Zaikova, Oleg N. Demidov, Alexina Shatilova, Larisa Girshova, Yu.D. Rogovaya, Irina Budaeva, Konstantin Bogdanov, D.V. Zaitsev, A.Yu. Zaritskey, Yu.V. Mirolyubova, Ekaterina Vasil’evna Belotserkovskaya, A.V. Petukhov, TS Nikulina
Publikováno v:
Clinical oncohematology. 14:13-21
Aim. To identify mutations in IDH1/IDH2, DNMT3A, and ASXL1 genes responsible for genome epigenetic regulation and their co-occurrence with FLT3, NPM1, and RUNX1 mutations in newly diagnosed adult acute myeloid leukemias (AML). Materials & Methods. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::446c22bcdbc83a30ec7d1c8a5033f447
https://doi.org/10.21320/2500-2139-2021-14-1-13-21
https://doi.org/10.21320/2500-2139-2021-14-1-13-21
Autor:
Daniil Zaytsev, Ekaterina Zaikova, Larisa Girshova, Dmitry Motorin, Ekaterina Vasil’evna Belotserkovskaya, A.V. Petukhov, VV Ivanov, A.Yu. Zaritskey, O.A. Fedorova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 13, Iss 2, Pp 150-160 (2019)
Background. FLT3 gene is an important prognostic molecular marker in acute myeloid leukemia (AML). However, the detection of FLT3 mutations presents a challenge. Aim. To compare techniques used for the detection of FLT3 mutations, and to develop a te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd14d8cc3de59774890175caea9299ff
https://doi.org/10.21320/2500-2139-2020-13-2-150-160
https://doi.org/10.21320/2500-2139-2020-13-2-150-160
Autor:
Ekaterina Vasil’evna Belotserkovskaya, Oleg N. Demidov, Vasily Golotin, Larisa Girshova, Andrey Zaritsky, Alexey Petukhov
Publikováno v:
Biological Communications. 66
Recently wild-type p53-induced phosphatase was implicated in the pathogenesis of acute myeloid leukemia (AML) and “pre-leukemia” myeloproliferative conditions. Here we decided to check how the strategy directed to phosphatase inhibition affected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::728fecd5a050d6212b8289b8d9e2a968
https://doi.org/10.21638/spbu03.2021.308
https://doi.org/10.21638/spbu03.2021.308
Autor:
Alexey Petukhov, Ekaterina Zaikova, Ksenia Levchuk, Ekaterina Vasil’evna Belotserkovskaya, Andrey Zaritskey, Danila Pozdnyakov
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S211-S212
Context AML is a severe blood pathology with a complicated therapy strategy and high risk of relapse. Objective Different types of cancer cells exhibit various expression rates of NKG2D ligands. An effective cell model is a crucial stage for profound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::886835fe53f7cac7aa62d4dfef0ebdc3
https://doi.org/10.1016/s2152-2650(20)30774-6
https://doi.org/10.1016/s2152-2650(20)30774-6